Go to deals
Private Equity | Healthcare

Leika Medical Equipments Ltd. has been acquired by Angus Capital

May 2024 — The shareholders of Leika Medical Equipments Ltd. have sold the company to Angus Capital.

Leika Medical Equipments Ltd. is a family-owned business specializing in the distribution and rental of wound care and pain relief products. The company provides high-end therapeutic equipment compliant with the established standards.

Angus Capital is a Canadian private equity fund specializing in the acquisition of SMEs in traditional industries. Its team is led by a group of multidisciplinary entrepreneurs who are actively involved in executing the growth plans of the companies in which they invest.

Our role in the transaction

Oaklins’ team in Canada advised the shareholders of Leika on the sale of the business to Angus Capital.

Parties
“I’m delighted to have found with Angus Capital a succession team driven by human and entrepreneurial values with the passion, know-how and expertise to pursue Leika’s mission. From beginning to end, the Oaklins team in Canada played a critical role in leading the process to a successful close. The level of service received and the final outcome exceeded my expectations. I warmly recommend Oaklins’ Canadian team to owners considering selling their company.”

Jean-Francois Tanguay

Shareholder, Leika Medical Equipments Ltd.

Talk to the deal team

Alexis Iché

Partner
Montreal, Canada
Oaklins Canada

Related deals

Cibus has acquired Aweta from Standard Investment
Private Equity | Agriculture | Industrial Machinery & Components

Cibus has acquired Aweta from Standard Investment

Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.

Learn more
Comtax has been acquired by Ryan
Private Equity | Business Support Services | TMT

Comtax has been acquired by Ryan

Comtax, a São Paulo-based tax technology consultancy specializing in tax determination and digital tax compliance, had been acquired by Ryan, the world’s largest firm dedicated exclusively to business taxes. The transaction marks Ryan’s entry into the Brazilian market, adding a specialized team and an established base of large corporate clients in Brazil, one of the world’s most complex tax environments, at a time when the country’s consumption tax reform is set to reshape how companies calculate and report indirect taxes. For Comtax, the acquisition brings access to Ryan’s global platform, technology and client network across more than 80 countries, creating opportunities to scale its tax determination and compliance offering beyond its current footprint. Comtax’s founders will continue to lead the business.

Learn more
Katalyst Diagnostics has been acquired by Cruinn Diagnostics
Healthcare

Katalyst Diagnostics has been acquired by Cruinn Diagnostics

Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.

Learn more